Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.

Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.
复制标题

Interleukin-22 可能是治疗 2 型糖尿病和冠状动脉疾病的双刃剑

DOI:
10.1155/2016/8254797
复制
发表时间:
2016
影响因子:
4.6
通讯作者:
Liu Z
Liu Z
中科院分区:
医学3区
文献类型:
--
作者:
Gong F;Wu J;Zhou P;Zhang M;Liu J;Liu Y;Lu X;Liu Z

文献摘要

参考文献

被引文献

相似文献

2型糖尿病(T2 DM)和冠心病(CAD)均以慢性低度炎症为特征。Th17及其相关细胞因子在T2 DM和CAD中的作用尚不清楚。在这里,我们研究了5种与Th17相关的细胞因子(IL-17、IL-22、MIP-3α、IL-9和IL-27)在T2 DM、冠心病和T2 DM-CAD共病患者中的水平。IL-22在三种情况下均升高。血清IL-22升高与T2 DM和CAD的发生独立相关。相反,IL-22对葡萄糖和溶血磷脂酰胆碱(LPC)诱导的内皮细胞损伤有保护作用,高糖和LPC处理后内皮细胞上IL-22R1的表达增加。用IL-22R1抗体阻断IL-22R1可减弱IL-22的保护作用。提示IL-22在T2 DM和CAD中起双刃剑作用,可用于T2 DM和CAD等慢性炎症性疾病的治疗。
Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are both characterized by chronic low-grade inflammation. The role of Th17 and its related cytokines in T2DM and CAD is unclear. Here we investigated the serum levels of five Th17-related cytokines (IL-17, IL-22, MIP-3α, IL-9, and IL-27) in T2DM, CAD, and T2DM-CAD comorbidity patients. IL-22 was found to be elevated in all three conditions. Elevated serum IL-22 was independently associated with the incidence of T2DM and CAD. Conversely, IL-22 was found to protect endothelial cells from glucose- and lysophosphatidylcholine- (LPC-) induced injury, and IL-22R1 expression on endothelial cells was increased upon treatment with high glucose and LPC. Blocking of IL-22R1 with IL-22R1 antibody diminished the protective role of IL-22. Our results suggest that IL-22 functions as a double-edged sword in T2DM and CAD and that IL-22 may be used in the treatment of chronic inflammatory diseases such as T2DM and CAD.
DOI: 10.4049/jimmunol.1302246
发表时间: 2015-11-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Peters A;Fowler KD;Chalmin F;Merkler D;Kuchroo VK;Pot C
通讯作者: Pot C
DOI: 10.4049/jimmunol.174.8.5047
发表时间: 2005-04-15
影响因子: 4.4
作者:
Pastore, S;Mascia, F;Girolomoni, G
通讯作者: Girolomoni, G
DOI: 10.3389/fendo.2013.00162
发表时间: 2013-10-29
影响因子: 5.2
作者:
Frostegård J
通讯作者: Frostegård J
DOI: 10.1093/eurheartj/eht149
发表时间: 2013-08
影响因子: 39.3
作者:
Paneni F;Beckman JA;Creager MA;Cosentino F
通讯作者: Cosentino F
DOI: 10.2337/db13-1511
发表时间: 2014-06-01
期刊: DIABETES
影响因子: 7.7
作者:
Dalmas, Elise;Venteclef, Nicolas;Guerre-Millo, Michele
通讯作者: Guerre-Millo, Michele